Online peer support for breast cancer survivors: A decentralized multicenter non-blinded parallel-group pilot randomized controlled trial (HOPE-BC study).

Y Yoshie Hasegawa (Department of Breast Surgery, Hachinohe City Hospital, Hachinohe, Aomori, Japan) K Ken Kurisu (Department of Cancer Survivorship and Digital Medicine, The Jikei University School of Medicine, Tokyo, Japan) T Takashi Yamanaka K Kentaro Tamaki (Department of Breast Surgery, Nahanishi Clinic, Naha-City, Okinawa, Japan) T Tomohiro Oshino T Tatsuya Toyama A Atsushi Fushimi (Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan) Y Yutaka Yamamoto H Hikari Konno (Department of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan) N Naomi Sakurai M Maiko Fujimori K Keita Mori T Takashi Itagaki (Accelight Inc., Tokyo, Japan) A Akifumi Kurata (Daiichi Sankyo Co., Ltd., Tokyo, Japan) T Tadahiro Izutani (Daiichi Sankyo Co., Ltd., Tokyo, Japan) A Asao Ogawa (Division of Psycho-Oncology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan) N Nobuya Akizuki (Department of Psycho-Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan) T Tatsuo Akechi (Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan) Y Yosuke Uchitomi (Division of Survivorship Research, National Cancer Center Institute for Cancer Control, National Cancer Center, Tokyo, Japan) T Toshinari Yamashita (Department of Breast Surgery and Oncology, Kanagawa Cancer Center, Yokohama, Japan)

Abstract

1668 Background: Peer support effectiveness for breast cancer survivors has reportedly varied, and no study has examined patient–supporter matching. This decentralized, multicenter, non-blinded pilot randomized controlled trial aimed to assess online peer support effectiveness and explore factors for a matching algorithm. Methods: Breast cancer survivors within three years of completing initial treatment were recruited and provided electronic informed consent. Based on the sample size estimation, the target sample size was set at 50. Participants were randomly assigned either to the peer support group, which scheduled an online peer support session immediately after registration, or to the waitlist group, which scheduled their session two weeks later. Participants could choose their preferred time and date through a web-based scheduling system. Peer support sessions were conducted online by two trained peer supporters. The primary outcome was the UCLA Loneliness Scale score, assessed one week after the session in the peer support group and at the end of the 2-week waiting period in the waitlist group. Secondary outcomes included satisfaction with peer support and other psychosocial measures, all collected through an electronic patient-reported outcome system. Effect sizes for outcomes were calculated to inform sample size estimation for future trials. Analyses were performed to explore factors associated with satisfaction. The study protocol was registered in the UMIN Clinical Trials Registry (UMIN000056741). Results: From February to July 2025, 54 participants enrolled and 52 individuals completed the study (27 peer support group, 25 waitlist group). At the primary endpoint, the mean (standard deviation) UCLA Loneliness Scale scores were 38.4 (11.2) in the peer support group and 41.3 (13.3) in the waitlist group (Cohen’s d = 0.24; t-test, P = 0.40). The change from baseline corresponded to a Cohen’s d = 0.32. Among the secondary outcomes, the changes in Generalized Anxiety Disorder-7 scores differed between groups (mean difference [MD] = -1.3; 95% CI = -2.5 to -0.1), and the changes in Patient Health Questionnaire-9 scores tended to be greater in the peer support group (MD = -1.2; 95% CI = -2.5 to 0.1). The global health status on EORTC QLQ-C30 did not differ between groups (MD = 1.0; 95% CI = -6.6 to 8.7). The median (IQR) satisfaction score was 46 (41.5, 50) on a 50-point scale. A linear mixed-effects model indicated that sharing ≥1 topic and age proximity between the participant and peer supporter were significantly associated with higher satisfaction. Conclusions: Results demonstrate the feasibility of future decentralized randomized trials on online peer support and provide effect size estimates to guide sample size planning. Shared topics and age proximity between participants and peer supporters may be considered when scheduling sessions.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
Pages 1668-1668
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (20)

Y

Yoshie Hasegawa

Department of Breast Surgery, Hachinohe City Hospital, Hachinohe, Aomori, Japan

K

Ken Kurisu

Department of Cancer Survivorship and Digital Medicine, The Jikei University School of Medicine, Tokyo, Japan

T

Takashi Yamanaka

K

Kentaro Tamaki

Department of Breast Surgery, Nahanishi Clinic, Naha-City, Okinawa, Japan

T

Tomohiro Oshino

T

Tatsuya Toyama

A

Atsushi Fushimi

Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan

Y

Yutaka Yamamoto

H

Hikari Konno

Department of Thoracic Surgery, Akita University Graduate School of Medicine, Akita, Japan

N

Naomi Sakurai

M

Maiko Fujimori

K

Keita Mori

T

Takashi Itagaki

Accelight Inc., Tokyo, Japan

A

Akifumi Kurata

Daiichi Sankyo Co., Ltd., Tokyo, Japan

T

Tadahiro Izutani

Daiichi Sankyo Co., Ltd., Tokyo, Japan

A

Asao Ogawa

Division of Psycho-Oncology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan

N

Nobuya Akizuki

Department of Psycho-Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan

T

Tatsuo Akechi

Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan

Y

Yosuke Uchitomi

Division of Survivorship Research, National Cancer Center Institute for Cancer Control, National Cancer Center, Tokyo, Japan

T

Toshinari Yamashita

Department of Breast Surgery and Oncology, Kanagawa Cancer Center, Yokohama, Japan